Temozolomide
CAS No. 85622-93-1
Temozolomide ( NSC-362856;CCRG-81045;TZM )
Catalog No. M16206 CAS No. 85622-93-1
An alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 38 | In Stock |
|
25MG | 61 | In Stock |
|
50MG | 74 | In Stock |
|
100MG | 87 | In Stock |
|
200MG | 116 | In Stock |
|
500MG | 152 | In Stock |
|
1G | 224 | In Stock |
|
Biological Information
-
Product NameTemozolomide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma.
-
DescriptionAn alkylating agent used as a treatment of some brain cancers, astrocytoma and glioblastoma; a prodrug and an imidazotetrazine derivative of the alkylating agent dacarbazine.Chemotherapeutic Agents Approved
-
SynonymsNSC-362856;CCRG-81045;TZM
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNAreplication
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number85622-93-1
-
Formula Weight194.15
-
Molecular FormulaC6H6N6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 33.33 mg/mL
-
SMILESO=C(C1=C(N2C=N1)N=NN(C)C2=O)N
-
Chemical NameImidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydro-3-methyl-4-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rao JU, et al. Sci Rep. 2017 Aug 11;7(1):7865.
2. Tateishi K, et al. Cancer Res. 2017 Aug 1;77(15):4102-4115.
3. Beier D, et al. Cancer Res. 2008 Jul 15;68(14):5706-15.
2. Tateishi K, et al. Cancer Res. 2017 Aug 1;77(15):4102-4115.
3. Beier D, et al. Cancer Res. 2008 Jul 15;68(14):5706-15.
molnova catalog
related products
-
Bisantrene
A small molecule DNA intercalater with antineoplastic activity, does not exhibit cardiotoxicity compared with doxorubicin; induces both protein-associated DNA single-strand breaks and DNA-protein crosslinks in cancer cells.
-
Streptozocin
Streptozotocin is a DNA alkylating agent that enters cells exclusively via the GLUT2 glucose transport protein.
-
Melflufen
Melflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.